EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Co-Assembly of Cancer Drugs with Cyclo-HH Peptides: Insights from Simulations and Experiments

Anastasia Vlachou iD, Vijay Bhooshan Kumar iD, Om Shanker Tiwari iD, Sigal Rencus-Lazar, Yu Chen iD, Busra Ozguney, Ehud Gazit iD, Phanourios Tamamis iD

ACS Applied Bio Materials · 2024

DOI: 10.1021/acsabm.3c01304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2024. Verfasst von Anastasia Vlachou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Artie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, Texas 77843-3122, United States. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States-Israel Binational Science Foundation, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptide-based nanomaterials can serve as promising drug delivery agents, facilitating the release of active pharmaceutical ingredients while reducing the risk of adverse reactions. We previously demonstrated that Cyclo-Histidine-Histidine (Cyclo-HH), co-assembled with cancer drug Epirubicin, zinc, and nitrate ions, can constitute an attractive drug delivery system, combining drug self-encapsulation, enhanced fluorescence, and the ability to transport the drug into cells. Here, we investigated both computationally and experimentally whether Cyclo-HH could co-assemble, in the presence of zinc and nitrate ions, with other cancer drugs with different physicochemical properties. Our studies indicated that Methotrexate, in addition to Epirubicin and its epimer Doxorubicin, and to a lesser extent Mitomycin-C and 5-Fluorouracil, have the capacity to co-assemble with Cyclo-HH, zinc, and nitrate ions, while a significantly lower propensity was observed for Cisplatin. Epirubicin, Doxorubicin, and Methorexate showed improved drug encapsulation and drug release properties, compared to Mitomycin-C and 5-Fluorouracil. We demonstrated the biocompatibility of the co-assembled systems, as well as their ability to intracellularly release the drugs, particularly for Epirubicin, Doxorubicin, and Methorexate. Zinc and nitrate were shown to be important in the co-assembly, coordinating with drugs and/or Cyclo-HH, thereby enabling drug-peptide as well as drug-drug interactions in successfully formed nanocarriers. The insights could be used in the future design of advanced cancer therapeutic systems with improved properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsEpirubicinHistidineMitomycinNitratesDoxorubicinPeptidesFluorouracilZinc

Stichwörter der Autor:innen

cancer drugsdrug encapsulationmolecular dynamics simulationspeptide co-assembly with drugspeptide self-assembly

Substanzen

EpirubicinHistidineMitomycinNitratesAntineoplastic AgentsDoxorubicinPeptidesFluorouracilZinc

Autor:innen und Institutionen

  • Artie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, Texas 77843-3122, United States.
  • The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Department of Materials Science and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Department of Materials Science and Engineering, Texas A&M University, College Station, Texas 77843-3003, United States.

ORCID-Profile: Anastasia Vlachou, Vijay Bhooshan Kumar, Om Shanker Tiwari, Yu Chen, Ehud Gazit, Phanourios Tamamis

Förderung

  • United States-Israel Binational Science Foundation
  • National Science Foundation

Zitieren

APA

Vlachou, A., Kumar, V. B., Tiwari, O. S., Rencus-Lazar, S., Chen, Y., Ozguney, B., Gazit, E., & Tamamis, P. (2024). Co-Assembly of Cancer Drugs with Cyclo-HH Peptides: Insights from Simulations and Experiments. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.3c01304

Vancouver

Vlachou A, Kumar VB, Tiwari OS, Rencus-Lazar S, Chen Y, Ozguney B, et al. Co-Assembly of Cancer Drugs with Cyclo-HH Peptides: Insights from Simulations and Experiments. ACS Applied Bio Materials. 2024. doi:10.1021/acsabm.3c01304

BibTeX
@article{Vlachou2024,
  author = {Vlachou, Anastasia and Kumar, Vijay Bhooshan and Tiwari, Om Shanker and Rencus-Lazar, Sigal and Chen, Yu and Ozguney, Busra and Gazit, Ehud and Tamamis, Phanourios},
  title = {Co-Assembly of Cancer Drugs with Cyclo-HH Peptides: Insights from Simulations and Experiments},
  journal = {ACS Applied Bio Materials},
  year = {2024},
  doi = {10.1021/acsabm.3c01304}
}
Kostenlos starten →